Can a simple test predict breast cancer brain spread?
NCT ID NCT07447544
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examines stored tumor tissue and blood samples from 22 women with early breast cancer to find genetic or chemical markers that might predict whether the cancer will spread to the brain. Researchers will compare women whose cancer did spread to the brain with those whose did not. The goal is to identify warning signs that could lead to earlier detection, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a blood or tissue test that identifies breast cancer patients at higher risk for brain metastases, allowing closer monitoring.
What could go wrong
This is a very small, observational study (22 people) that only looks for patterns. It does not test any treatment, so any potential test would need much larger studies to confirm.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia